Pathogenesis of osteoporosis: concepts, conflicts, and prospects - Wikidata - awgldk - TriplyDB

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

http://www.wikidata.org/entity/Q24536164

about

Role of RANKL inhibition in osteoporosis Steroidal contraceptives: effect on bone fractures in women Chinese herbal medicines for treating osteoporosis Steroidal contraceptives: effect on bone fractures in women Steroidal contraceptives: effect on bone fractures in women Eldecalcitol is more effective for the prevention of osteoporotic fractures than alfacalcidol Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene Once-yearly zoledronic acid in hip fracture prevention Osteoimmune Interactions in Inflammatory Bowel Disease: Central Role of Bone Marrow Th17 TNFα Cells in Osteoclastogenesis Role of Nrf2 in bone metabolism Molecular Aspects of Bone Resorption in β-Thalassemia Major Cholecalciferol and Cancer: Is It a Big D3-eal?Nuclear receptors in bone physiology and diseases Regulation and function of the FGF23/klotho endocrine pathways Pituitary disorders and osteoporosis Vitamin D, calcium homeostasis and aging Differentiation of Bone Marrow Mesenchymal Stem Cells in Osteoblasts and Adipocytes and its Role in Treatment of Osteoporosis General Diseases Influence on Peri-Implantitis Development: a Systematic Review Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy Disorders of bone remodeling Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents Akt promotes BMP2-mediated osteoblast differentiation and bone development Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion Insulin receptor substrate 2 plays important roles in 17beta-estradiol-induced bone formation Treadmill training regulates β-catenin signaling through phosphorylation of GSK-3β in lumbar vertebrae of ovariectomized rats Synergistic effects of green tea polyphenols and alphacalcidol on chronic inflammation-induced bone loss in female rats Claudin 18 is a novel negative regulator of bone resorption and osteoclast differentiation Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions Drivers of age-related inflammation and strategies for healthspan extension Influence of Adolescents' Physical Activity on Bone Mineral Acquisition: A Systematic Review Article Resistance Training Is an Effective Tool against Metabolic and Frailty Syndromes.Absence of ERRalpha in female mice confers resistance to bone loss induced by age or estrogen-deficiency Role of Curcumin in Common Musculoskeletal Disorders: a Review of Current Laboratory, Translational, and Clinical Data.Solid-State Quantitative (1)H and (31)P MRI of Cortical Bone in Humans.Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype.Impact exercise increases BMC during growth: an 8-year longitudinal study.PLCL1 rs7595412 variation is not associated with hip bone size variation in postmenopausal Danish women.PTH increases jaw mineral density in a rabbit model of osteoporosis.Concerted stimuli regulating osteo-chondral differentiation from stem cells: phenotype acquisition regulated by microRNAs.

P2860

Q21195417-79EC070E-FBE4-42C2-8309-A6748D93FA59 Q24193793-0AE3464D-322C-456E-A118-03950CB79A73 Q24198040-6BCD1E4C-B30F-4A6D-9F20-5603A1D62613 Q24235567-5D22F45F-C503-4582-BF42-2C21E1002F4C Q24240975-CCF87D42-B9C8-4A9A-AC4F-E58EF64D0C75 Q24601118-3551A212-5C91-40B5-B964-D8AC6F5456D8 Q24652524-CDFE04DB-DA4A-492B-82CF-7121B72365E9 Q24657667-9C5A459E-2821-4455-903C-362426B8F5C7 Q26770666-61E98571-C3DB-42E3-9AD7-C049AEA552C2 Q26778148-C118F4F8-3696-4D61-A2FD-28EA700C53FA Q26801066-19B5562D-2AD4-4AB6-A8F4-B0EA79B8EC7F Q26852226-FE4FB008-68BD-438A-ADFF-5F5772A7CA32 Q26853017-E362FE25-8895-4D5E-B6B5-AC682DDDFEF1 Q26860470-29DA519D-CB99-4302-B183-764BB6506AA8 Q27008465-E5EABCDE-8736-4A90-B024-D075F5EF9CAF Q28073460-3D06F050-4518-4632-B22B-22598CF51224 Q28077985-CBEB07A7-BEAA-4309-A246-7BCEABDA0BDB Q28080199-9903255E-1E09-4448-8D0E-1C01E053C038 Q28253298-B4A90D93-1912-4068-AD82-08B1AA97C847 Q28295303-B4584B62-6779-4923-88DD-6E086FE8C179 Q28473076-58251F8F-C2C1-46B7-8DB3-4532E103E9AB Q28511143-8FC4C2AA-86F5-4024-96CA-6EBCD5CA7857 Q28512093-3DF7F77B-4811-4561-9203-754F9E7C2E72 Q28567293-FCB26999-1062-4C98-8FE9-04C1152074BF Q28569257-7926EF47-9F84-4FB8-B537-B6B36BDCEC01 Q28576330-6D4D5CB9-E813-4252-ADE3-79A43F3DBA7B Q28589537-78C4C258-9BBE-4121-B2D9-FD2EBFC69A6E Q28593384-8F712B12-A3FF-4D03-B9C3-214E969289CF Q28649560-7A3C0AC8-8E93-4C6B-9FF3-524B69ECE209 Q30239818-BAF6F78A-35CB-4A16-A8E2-72C8B347ACFA Q30408045-ECD52735-51FC-4ED0-B384-7030250EFD0D Q30912751-B27C3B0A-5A16-4241-AC1F-F8E94A78BB1D Q30989974-EF77E0AA-E186-455F-A116-0945CE5EF1EF Q31069297-8086617F-4220-40A6-87DB-7B82343DA2D6 Q33290977-3D72E83B-EA82-49BE-9A65-8F637790D746 Q33307072-03007077-A7B9-4147-BDE6-1080B26DA5E1 Q33309739-45C8AB1D-1E1B-4ED6-B0CE-F77057A4B520 Q33520534-B22DF5A4-71D9-4585-86DB-44887014C702 Q33533559-6FAD9E0B-7023-4EF3-90F2-165CBCA02D6F Q33555616-72F41A44-0D25-442F-AE21-925CE8BB9245

P2860

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

http://www.wikidata.org/entity/Q24536164

description

2005 nî lūn-bûn

@nan

2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@ast

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@en

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@en-gb

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@nl

type

label

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@ast

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@en

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@en-gb

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@nl

prefLabel

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@ast

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@en

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@en-gb

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@nl

P1433

Q24536164-7D8CE317-D144-473B-B5B1-2246BF67B760

P1476

Q24536164-48FE5788-3286-44CF-B7D8-CB48BD968337

P2093

Q24536164-A2FBA9DD-0560-41C7-B9F9-114659670EF9

P2860

Q24536164-00252A66-5F1F-4B1F-82D0-C7787719BC12

Q24536164-02CE11DE-97E0-42D9-B070-2668FEC5FCB3

Q24536164-05D1F5A7-E2F7-4764-A98B-62213DAD16E7

Q24536164-063A373C-A8FD-4AAB-BCFE-5ECC9FFC2E94

Q24536164-0AEB0475-4D7E-4899-B2AC-078782D6C86B

Q24536164-0CE41EE7-1123-4CCA-8013-2A8C8839A4A8

Q24536164-0D587151-DDAF-4C26-8E73-0E8DE70AC77F

Q24536164-1074A38A-D41F-4A9B-B11D-B0BE2F07A4B3

Q24536164-120DF037-494F-4399-8B5C-8837B4D85F2F

Q24536164-140CF36B-08F1-4F7F-B7E8-DC8EDFA0C96B

P304

Q24536164-BC17A749-7C63-40EF-B37C-D993A227874F

P31

Q24536164-F37E05C3-3F98-4FEF-92D9-2171D26708E2

P3181

Q24536164-493FD056-0D5E-4BB9-B81D-C3F5C6278934

P356

Q24536164-6304A5D8-6C3E-44DD-89CB-DA0D4FEF9ECB

P407

Q24536164-D0820387-6095-417F-8581-FF5679440F54

P433

Q24536164-450381AA-90B6-450F-A734-3A23247F790C

P478

Q24536164-0A85926F-997B-41C7-9902-D431774E39EE

P577

Q24536164-4A8E0A89-7D6E-454F-B2E7-257C194C7656

P698

Q24536164-289F1764-C142-4F16-9BA0-D8ADEA71BA2D

P921

Q24536164-A809F54A-3336-4FC4-9A21-AFCF6E3A3A80

Q24536164-BE856019-D6E6-4BA1-99C2-02BF6FE22A9D

P932

Q24536164-6A6D4945-FEF9-4A8E-B98D-3B228CFE2DB0

P3181

P356

P1433

Journal of Clinical Investigation

P1476

Pathogenesis of osteoporosis: concepts, conflicts, and prospects

@en

P2093

Lawrence G Raisz

http://www.w3.org/2001/XMLSchema#string

P2860

Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)

The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation

The Wnt antagonist secreted frizzled-related protein-1 controls osteoblast and osteocyte apoptosis

Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density

A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Linkage of osteoporosis to chromosome 20p12 and association to BMP2

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families

Association between bone mineral density and the use of nonsteroidal anti-inflammatory drugs and aspirin: impact of cyclooxygenase selectivity

Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture

P304

3318-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

684232

http://www.w3.org/2001/XMLSchema#string

P356

10.1172/JCI27071

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P577

2005-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16322775

http://www.w3.org/2001/XMLSchema#string

P921

P932

1297264

http://www.w3.org/2001/XMLSchema#string